Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells.
Hasegawa H, Yamada Y, Komiyama K, Hayashi M, Ishibashi M, Yoshida T, Sakai T, Koyano T, Kam TS, Murata K, Sugahara K, Tsuruda K, Akamatsu N, Tsukasaki K, Masuda M, Takasu N, Kamihira S. Hasegawa H, et al. Among authors: masuda m. Blood. 2006 Jan 15;107(2):679-88. doi: 10.1182/blood-2005-05-1982. Epub 2005 Sep 29. Blood. 2006. PMID: 16195335 Free article.
A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production.
Hasegawa H, Yamada Y, Komiyama K, Hayashi M, Ishibashi M, Sunazuka T, Izuhara T, Sugahara K, Tsuruda K, Masuda M, Takasu N, Tsukasaki K, Tomonaga M, Kamihira S. Hasegawa H, et al. Among authors: masuda m. Blood. 2007 Sep 1;110(5):1664-74. doi: 10.1182/blood-2007-01-068981. Epub 2007 Jun 5. Blood. 2007. PMID: 17551094 Free article. Clinical Trial.
Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N. Matsuda T, et al. Among authors: masuda m. J Virol. 2005 Feb;79(3):1367-78. doi: 10.1128/JVI.79.3.1367-1378.2005. J Virol. 2005. Retraction in: J Virol. 2011 Feb;85(3):1416. doi: 10.1128/JVI.02070-10 PMID: 15650163 Free PMC article. Retracted.
Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N. Tomita M, et al. Among authors: masuda m. Int J Cancer. 2006 Feb 1;118(3):765-72. doi: 10.1002/ijc.21389. Int J Cancer. 2006. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387 PMID: 16106398 Retracted.
NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.
Okudaira T, Tomita M, Uchihara JN, Matsuda T, Ishikawa C, Kawakami H, Masuda M, Tanaka Y, Ohshiro K, Takasu N, Mori N. Okudaira T, et al. Among authors: masuda m. Mol Cancer Ther. 2006 Mar;5(3):704-12. doi: 10.1158/1535-7163.MCT-05-0434. Mol Cancer Ther. 2006. PMID: 16546985
Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.
Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Mori N. Tomita M, et al. Among authors: masuda m. Leuk Res. 2006 Mar;30(3):313-21. doi: 10.1016/j.leukres.2005.08.004. Epub 2005 Sep 12. Leuk Res. 2006. Retraction in: Leuk Res. 2011 Aug;35(8):1130. doi: 10.1016/j.leukres.2011.06.009 Retraction in: Leuk Res. 2012 May;36(5):661. doi: 10.1016/j.leukres.2012.01.014 PMID: 16157375 Retracted.
2,700 results